- Home
- LESL vs ENTA Comparison
LESL vs ENTA Comparison
Compare LESL & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LESL
- ENTA
- Stock Information
- Founded
- LESL 1963
- ENTA 1995
- Country
- LESL United States
- ENTA United States
- Employees
- LESL N/A
- ENTA N/A
- Industry
- LESL Diversified Commercial Services
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- LESL Miscellaneous
- ENTA Health Care
- Exchange
- LESL Nasdaq
- ENTA Nasdaq
- Market Cap
- LESL 147.4M
- ENTA 160.3M
- IPO Year
- LESL 2020
- ENTA 2013
- Fundamental
- Price
- LESL $0.49
- ENTA $7.28
- Analyst Decision
- LESL Hold
- ENTA Buy
- Analyst Count
- LESL 11
- ENTA 4
- Target Price
- LESL $2.32
- ENTA $18.00
- AVG Volume (30 Days)
- LESL 2.6M
- ENTA 168.6K
- Earning Date
- LESL 08-06-2025
- ENTA 08-04-2025
- Dividend Yield
- LESL N/A
- ENTA N/A
- EPS Growth
- LESL N/A
- ENTA N/A
- EPS
- LESL N/A
- ENTA N/A
- Revenue
- LESL $1,319,859,000.00
- ENTA $64,462,999.00
- Revenue This Year
- LESL $1.64
- ENTA N/A
- Revenue Next Year
- LESL $2.74
- ENTA $0.48
- P/E Ratio
- LESL N/A
- ENTA N/A
- Revenue Growth
- LESL N/A
- ENTA N/A
- 52 Week Low
- LESL $0.45
- ENTA $4.09
- 52 Week High
- LESL $4.51
- ENTA $17.24
- Technical
- Relative Strength Index (RSI)
- LESL 28.98
- ENTA 60.14
- Support Level
- LESL $0.45
- ENTA $6.87
- Resistance Level
- LESL $0.58
- ENTA $8.47
- Average True Range (ATR)
- LESL 0.06
- ENTA 0.50
- MACD
- LESL -0.03
- ENTA -0.03
- Stochastic Oscillator
- LESL 11.28
- ENTA 54.44
About LESL Leslie's Inc.
Leslies Inc is a direct-to-consumer pool and spa care brand offering a comprehensive assortment of products across chemicals, equipment and parts, cleaning and maintenance equipment, and safety, recreational, and fitness-related products. The company offers its products and services for Residential Pool, Residential Spa, Professional Pool, and Commercial Pool consumers. Geographically, it operates only in the United States.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.